Effect of prophylactic medication and influence of vitreous reflux in pressure rise after intravitreal injections of anti-VEGF drugs. [electronic resource]
Producer: 20141114Description: 771-7 p. digitalISSN:- 1724-6016
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antihypertensive Agents -- administration & dosage
- Bevacizumab
- Brimonidine Tartrate
- Drug Combinations
- Eye Diseases
- Female
- Humans
- Intraocular Pressure -- drug effects
- Intravitreal Injections
- Male
- Middle Aged
- Ocular Hypertension -- etiology
- Pressure
- Prospective Studies
- Quinoxalines -- administration & dosage
- Ranibizumab
- Retinal Diseases -- drug therapy
- Timolol -- administration & dosage
- Tonometry, Ocular
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Vitreous Body -- pathology
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.